Analgesics and pain relief in pregnancy and breastfeeding

Australian Prescriber

Volumn 34, Issue 1, 2011, Pages 8-10

  Kennedy, Debra ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Codeine; Non steroidal anti inflammatory drugs; Opioids; Paracetamol

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; CODEINE; CYTOCHROME P450 2D6; DICLOFENAC; DRUG METABOLITE; IBUPROFEN; MORPHINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; TRICYCLIC ANTIDEPRESSANT AGENT;

ANALGESIA; ARTICLE; BREAST FEEDING; CENTRAL NERVOUS SYSTEM DEPRESSION; DRUG INDICATION; DRUG MEGADOSE; DRUG METABOLISM; DRUG MILK LEVEL; DRUG SAFETY; FEVER; FIRST TRIMESTER PREGNANCY; GENETIC POLYMORPHISM; GESTATIONAL AGE; HUMAN; LOW DRUG DOSE; PAIN; PAIN ASSESSMENT; PHARMACOGENETICS; PREGNANCY; PRENATAL DRUG EXPOSURE; REYE SYNDROME; RISK BENEFIT ANALYSIS; RISK REDUCTION; SIDE EFFECT; SPONTANEOUS ABORTION; THIRD TRIMESTER PREGNANCY; WITHDRAWAL SYNDROME; WOMEN'S HEALTH;

EID: 79851494297     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2011.007     Document Type: Article

References (12)

1. Henry A, Crowther C. Patterns of medication use during and prior to pregnancy: the MAP study. Aust N Z J Obstet Gynaecol 2000;40:165-72.
2. Rebordosa C, Kogevinas M, Horvath-Puho E, Norgard B, Morales M, Czeizel AE, et al. Acetaminophen use during pregnancy: effects on risk for congenital abnormalities. Am J Obstet Gynecol 2008;198:178. e1-7.
3. Erkan D, Patel S, Nuzzo M, Gerosa M, Meroni PL, Tincani A, et al. Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers. Rheumatology (Oxford) 2008;47 Suppl 3:iii23-7.
4. Kozer E, Nikfar S, Costei A, Boskovic R, Nulman I, Koren G. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 2002;187:1623-30.
5. Nielsen GL, Sorensen HT, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ 2001;322:266-70.
6. Li DK, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 2003;327:368.
7. Gloor JM, Muchant DG, Norling LL. Prenatal maternal indomethacin use resulting in prolonged neonatal renal insufficiency. J Perinatol 1993;13:425-7.
8. van der Heijden BJ, Carlus C, Narcy F, Bavoux F, Delezoide AL, Gubler MC. Persistent anuria, neonatal death, and renal microcystic lesions after prenatal exposure to indomethacin. Am J Obstet Gynecol 1994;171:617-23.
9. Nulman I, Rovet J, Stewart DE, Wolpin J, Pace-Asciak P, Shuhaiber S, et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 2002;159:1889-95.
10. Hale TW. Medications and mothers' milk. 14th ed. Amarillo (TX): Hale Publishing; 2010.
11. Koren G, Cairns J, Chitayat D, Gaedigk A, Leeder SJ. Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet 2006;368:704.
12. Madadi P, Moretti M, Djokanovic N, Bozzo P, Nulman I, Ito S, et al. Guidelines for maternal codeine use during breastfeeding. Can Fam Physician 2009;55:1077-8.